Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Completed
National Cancer Institute (NCI)
Phase 2
2003-10-01
RATIONALE: Drugs used in chemotherapy, such as docetaxel, use different ways to stop tumor
cells from dividing so they stop growing or die. It is not yet known which docetaxel regimen
is more effective for non-small cell lung cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of two regimens of docetaxel
in treating patients who have not previously received chemotherapy for unresectable stage
IIIB or stage IV non-small cell lung cancer.
Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Completed
Case Comprehensive Cancer Center
Phase 2
2003-10-01
RATIONALE: Drugs used in chemotherapy, such as docetaxel, use different ways to stop tumor
cells from dividing so they stop growing or die. It is not yet known which docetaxel regimen
is more effective for non-small cell lung cancer.
PURPOSE: Randomized phase II trial to compare the effectiveness of two regimens of docetaxel
in treating patients who have not previously received chemotherapy for unresectable stage
IIIB or stage IV non-small cell lung cancer.
Study of Oxaliplatin and Taxotere in Prostate Cancer
Completed
Sanofi
Phase 2
2004-11-01
The primary objective for this study is to evaluate PSA response rates (response will be
defined as a > 50% reduction in PSA levels) in men who have failed primary chemotherapy. The
secondary objectives are to compare progression free survival, disease free survival, overall
survival, and toxicity (tolerance/safety).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
